Concepedia

Vladislav A. Korobeynikov

VA

8

Publications

556

Citations

8

H-Index

2015

Active since

Affiliations

Columbia University(Current)

Fox Chase Cancer Center

Yale University

Ionis Pharmaceuticals (United States)

Synta Pharmaceuticals (United States)

Vladislav A. Korobeynikov is an author at Columbia University specializing in gene delivery, molecular biology, and neurodegenerative diseases.

ORCID

Top concepts

Publications per year

2015–2025

8

Publications

8

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis

Vladislav A. Korobeynikov, Alexander K. Lyashchenko, Beatriz Blanco-Redondo et al. · Nature Medicine · 2022 · 249 citations · Full text

Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4

Laura Campisi, Shahab Chizari, Jessica Ho et al. · Nature · 2022 · 83 citations · Full text

, , +3

Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer

Tim N. Beck, Vladislav A. Korobeynikov, Alexander E. Kudinov et al. · Cell Reports · 2016 · 70 citations · Full text

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer

Vladislav A. Korobeynikov, Michelle Borakove, Yayi Feng et al. · Breast Cancer Research and Treatment · 2019 · 42 citations · Full text

Ganetespib limits ciliation and cystogenesis in autosomal‐dominant polycystic kidney disease (ADPKD)

Anna S. Nikonova, Alexander Y. Deneka, Anna A. Kiseleva et al. · The FASEB Journal · 2018 · 36 citations · Full text

Rows per page

1–5 of 8